Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMBINE: Pharmacotherapies and Behavioral Interventions for Alcohol Dependence
NCT00006206Phase 3Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Aug 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of naltrexone and acamprosate in alcohol dependence (9 arms), sponsored by University of North Carolina at Chapel Hill. Primary endpoints: Percent Days Abstinent at 16 weeks and Time to Relapse to Heavy Drinking at 16 weeks. Started Aug 1997; status: completed.
02
Drugs
naltrexoneacamprosate
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00006206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006206.